Computer Enabled Neuroplasticity Treatment : A Clinical Trial of a Novel Design for Neurofeedback Therapy in Adult ADHD by Cowley, Benjamin et al.
CLINICAL TRIAL
published: 09 May 2016
doi: 10.3389/fnhum.2016.00205
Frontiers in Human Neuroscience | www.frontiersin.org 1 May 2016 | Volume 10 | Article 205
Edited by:
Soledad Ballesteros,
Universidad Nacional de Educación a
Distancia, Spain
Reviewed by:
Lutz Jäncke,
University of Zurich, Switzerland
Juliana Yordanova,
Bulgarian Academy of Sciences,
Bulgaria
*Correspondence:
Benjamin Cowley
benjamin.cowley@ttl.fi
Received: 13 January 2016
Accepted: 22 April 2016
Published: 09 May 2016
Citation:
Cowley B, Holmström É, Juurmaa K,
Kovarskis L and Krause CM (2016)
Computer Enabled Neuroplasticity
Treatment: A Clinical Trial of a Novel
Design for Neurofeedback Therapy in
Adult ADHD.
Front. Hum. Neurosci. 10:205.
doi: 10.3389/fnhum.2016.00205
Computer Enabled Neuroplasticity
Treatment: A Clinical Trial of a Novel
Design for Neurofeedback Therapy in
Adult ADHD
Benjamin Cowley 1, 2*, Édua Holmström 3, Kristiina Juurmaa 2, Levas Kovarskis 3 and
Christina M. Krause 2
1 BrainWork Research Centre, Finnish Institute of Occupational Health, Helsinki, Finland, 2Cognitive Brain Research Unit,
Cognitive Science, Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland, 3 Formally affiliated with Faculty
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Background: We report a randomized controlled clinical trial of neurofeedback therapy
intervention for ADHD/ADD in adults. We focus on internal mechanics of neurofeedback
learning, to elucidate the primary role of cortical self-regulation in neurofeedback. We
report initial results; more extensive analysis will follow.
Methods: Trial has two phases: intervention and follow-up. The intervention consisted
of neurofeedback treatment, including intake and outtake measurements, using a
waiting-list control group. Treatment involved ∼40 h-long sessions 2–5 times per week.
Training involved either theta/beta or sensorimotor-rhythm regimes, adapted by adding
a novel “inverse-training” condition to promote self-regulation. Follow-up (ongoing) will
consist of self-report and executive function tests.
Setting: Intake and outtake measurements were conducted at University of Helsinki.
Treatment was administered at partner clinic Mental Capital Care, Helsinki.
Randomization: We randomly allocated half the sample then adaptively allocated the
remainder to minimize baseline differences in prognostic variables.
Blinding: Waiting-list control design meant trial was not blinded.
Participants: Fifty-four adult Finnish participants (mean age 36 years; 29 females) were
recruited after screening by psychiatric review. Forty-four had ADHD diagnoses, 10 had
ADD.
Measurements: Symptoms were assessed by computerized attention test (T.O.V.A.)
and self-report scales, at intake and outtake. Performance during neurofeedback trials
was recorded.
Results: Participants were recruited and completed intake measurements during
summer 2012, before assignment to treatment and control, September 2012. Outtake
measurements ran April-August 2013. After dropouts, 23 treatment and 21 waiting-list
participants remained for analysis.
Initial analysis showed that, compared to waiting-list control, neurofeedback
promoted improvement of self-reported ADHD symptoms, but did not show
transfer of learning to T.O.V.A. Comprehensive analysis will be reported elsewhere.
Cowley et al. Clinical Trial of Novel Neurofeedback Design
Trial Registration: “Computer Enabled Neuroplasticity Treatment (CENT),”
ISRCTN13915109.
Keywords: neurofeedback, attention deficit/hyperactivity disorder, attention deficit disorder, adult, randomized
controlled trial, waiting list control, learning curves, learning transfer
1. INTRODUCTION
Attention Deficit/Hyperactivity Disorder (ADHD) is a
neurobiological condition which can strongly affect several
areas of life: lower socio-economic status, less satisfaction with
employment and marriage, as well as common co-occurrence of
conditions like addiction and depression. Epidemiology research
has estimated the prevalence of ADHD among adults to be 4.4%.
Subtypes of ADHD have been identified including Inattentive
(ADHD-I), Hyperactive (ADHD-H) and combined (ADHD-C).
However, the nature of the disease and most effective method of
treatment are still not well understood.
This open-label clinical trial is a test of neurofeedback (NFB)
as a treatment intervention for ADHD or ADD-diagnosed
adults1. The intervention is based on the NFB training regimes
“theta-beta” (TB) and “sensorimotor rhythm” (SMR). These
regimes train self-regulation of power in specific bands of the
EEG frequency spectrum, through the principle of operant
conditioning. The trial also includes the novel addition of
a third type of training, “inverse training,” designed to help
investigate the relationship between NFB learning performance
(the requirement to self-regulate) and the specific effects of each
training regime. This follows recent calls for increased focus on
the internal mechanics of the NFB process by Gevensleben et al.
(2014) and Zuberer et al. (2015), in order to attempt more than
just another simple test of efficacy.
We test intervention efficacy in a between-subjects manner
using a waiting-list control (WLC) group. The trial thus relies
on three different levels of measurements: neurophysiological,
cognitive, and behavioral; and examines their relationship across
multiple time-points. Transfer of learning is measured by:
questionnaires tapping ADHD/ADD symptoms that participants
filled out at four time-points during the intervention; and
by performance on a continuous performance test. More
importantly, given our focus on mechanics, we also test specific
effects of the NFB training regimes by analysing within-subjects
learning curves (LCs) of the treatment group, which represent
how they learn to self-regulate their EEG-band activity.
Abbreviations:ADHD, AttentionDeficit/Hyperactivity Disorder; ADD, Attention
Deficit Disorder; BCIA, Biofeedback Certification International Alliance; CENT,
Computer Enabled Neuroplasticity Treatment; CNV, Contingent Negative
Variation; IBS, Institute of Behavioral Science; MCC, Mental Capital Care
(clinic); NFB, neurofeedback; RCT, randomized controlled trial; SCP, Slow
Cortical Potentials (neurofeedback training regime); SMR, SensoriMotor Rhythm
(neurofeedback training regime); TB, Theta/Beta (neurofeedback training regime);
T.O.V.A., Test Of Variables of Attention; UoH, University of Helsinki; WLC,
waiting list control.
1The ICD-10 diagnosis classification system is in use in Finland where the study
was conducted. Both ADD and ADHD are used as diagnoses, the former referring
to the predominantly inattentive type, as opposed to predominantly hyperactive or
combined types.
At the time of writing this is an ongoing two phase
trial, where phase 1 included intake measurements, NFB
intervention, and outtake (all complete), and phase 2 will include
follow-up measurements and WLC treatment opportunity
(pending). In addition to the protocol structure, we report
an initial group-comparison result from the first phase,
showing mixed outcomes for efficacy. This result is primarily
included to illustrate the importance of the planned within-
subjects analysis for obtaining clear insights from the data
gathered.
1.1. Attention Deficit/Hyperactive Disorder
Models seeking to explain the cognitive neuropsychological
problems associated with ADHD include disturbance of
attention, cortical arousal, and executive functions (for review
see e.g., Sergeant et al., 2003; Seidman, 2006). However, a
meta-analysis by Huang-Pollock and Nigg (2003) discarded the
explanatory value of attention, at least in individuals diagnosed
with the combined subtype of ADHD. Increasingly, ADHD is
not seen as a disorder of attention at all but as a disorder in
key aspects of self-regulation and executive functions (Nigg,
2005). One caveat is the growing consensus that the executive
function “single deficit” model cannot sufficiently explain ADHD
(Nigg, 2005; Pennington, 2005; Sonuga-Barke, 2005). Studies
indicate that not all persons with ADHD have executive function
deficits — at least as measured by laboratory tests.
Cortical arousal models in ADHD are closely related to
the attentional concept of alerting as proposed by Posner and
Petersen (1990), reflecting right-lateralized vigilance network
with noradrenergic involvement. These models emphasize
deficiencies in the early stages of information processing as
a result of under-arousal in cortical systems (Sergeant et al.,
1999). EEG and ERP findings tend to support this model in
that they reveal excess slow-wave activity in adults with ADHD
(Bresnahan et al., 1999). Support also comes from consistent
findings of deficit in the continuous performance test (CPT) d-
prime parameter, which can be considered a consensus index
of arousal (Losier et al., 1996). Epstein et al. (2003) found that
the d-prime demonstrated very robust relationships to the 18
DSMV-IV ADHD symptoms.
EEG studies suggest that ADHD might stem either from
a maturational lag or a developmental deviation (Barry et al.,
2003). Maturational lag models require that EEG measures
from an individual with ADHD would be considered normal
in a younger person, and implies that ADHD adults grow
out of their immature EEG activity with increasing age (Mann
et al., 1992). Whereas in the developmental deviation model,
ADHD is conceptualized as resulting from an abnormality in
the functioning of the central nervous system, unlikely to change
without targeted intervention.
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Longitudinal studies, reviewed by Bresnahan et al. (1999), that
followed participants up till adulthood revealed that although
there is a significant reduction of slow wave activity in both
the ADHD and the control group with increasing age, absolute
and relative theta activity remained elevated through adolescence
into adulthood (Bresnahan and Barry, 2002). Interestingly, with
increasing age, the level of beta activity produced by adults
with ADHD was normalized in the frontocentral regions. The
most consistent finding from EEG studies of ADHD in adults is
increased absolute power in theta, clearly visible in frontocentral
areas (Bresnahan et al., 1999; Lazzaro et al., 1999; Clarke et al.,
2001). Such findings contradict thematurational lagmodel, as the
difference in slow activity does not disappear with increasing age.
By contrast, the hypo-arousal developmental deviation model
originally proposed by Satterfield et al. (1974) has been supported
by cerebral blood flow and positron emission tomography studies
(Lou et al., 1989; Zametkin et al., 1990). This model proposes
that ADHD results from cortical under-arousal, and the observed
atypical slow wave activity confirms the existence of altered brain
activity among adults with ADHD. Hypo-arousal is thought
to correlate with both beta and SMR (sensory motor rhythm,
also called low beta), because in normal functioning, increased
beta is associated with mental activity, and decreased SMR with
physical activity.
Much of the existing research has identified maturational lag
or hypo-arousal as the underlying cause of ADHD. Although
these models have initiated extensive research, they have failed to
clarify the aetiology of the disorder (Bresnahan et al., 1999). Thus,
the literature suggests that, at least in adult ADHD, aetiological
specificity is lacking; with the consequence that traditional
treatments targeted at ADHD as a single disorder are unlikely
to be reliable. In contrast, personalized medicine emphasizes
heterogeneity within a given disorder, relying on biomarkers or
endophenotypes to guide different treatments.
1.2. Neurofeedback
NFB, also called EEG biofeedback, is operant conditioning of
specific temporal, spatial and frequency features extracted from
scalp-recorded electrical potentials (Lubar and Shouse, 1976).
Feedback is presented to the treated individual in the form of
positive and negative reinforcers (in this study: visual reinforcers)
whenever their ongoing EEG features meet or fail to meet a
predefined criterion. The aim of NFB is to learn to gain control
of those EEG features over time.
Literature supports the efficacy of NFB for children with
ADHD (Arns et al., 2009, 2014b; Micoulaud-Franchi et al., 2014).
Part of its value is that NFB can be personalized to suit the specific
clinical presentation, provided that there is requisite theoretical
and observational data to guide the personalization.
NFB has been described as a mechanism that can stimulate
cortical arousal and/or regulate cortical oscillations, which in
turn may influence such cognitive activity as attention (Vernon
et al., 2003). The specific effect has been described variously as
following one of two models, termed by Gevensleben et al. (2014)
as “conditioning- and-repairing model” vs. “skill-acquisition
model.” This implies that the effect of NFB may be to repair
a presumed cause of disorder to normalize behavior, or instead
may be a tool to enhance cognitive performance (see Gevensleben
et al., 2014 for a thorough discussion).
It has been suggested that, besides the neurophysiological
aspects of NFB, treatment outcome depends greatly on the
subjective involvement of the patient. Calderon and Thompson
(2004) have conceptualized biofeedback as a three-step process
that consists of
• becoming aware of a physiological response,
• learning to control the response, and
• transferring control of the response to everyday life.
The first two steps of the model — becoming aware and learning
to control the electrical activity of the brain — constitute NFB
learning. The third step refers to transfer of the NFB learning,
measured here by performance on a neurocognitive test as well
as self-reported ADHD related symptoms.
This study employs two kinds of separate NFB training
regimes: theta/beta and sensimotor-rhythm. Additionally, we
included a novel “inverse mode” of training, which is a
modification of each of these two regimes. Finally, transfer
trials during which the patient is given no visual feedback were
included toward the end of the trial.
Theta/beta (TB) training regime assumes a theta power that
is elevated above normal, and therefore uses an inhibition target
for theta power and a reinforcement target for beta power. EEG
recording is often at a frontal site. The rationale behind TB
training has been described in at least two different ways: as the
rectification of cortical hypoarousal (Barry et al., 2003), and as
the reinforcement of working memory (Vernon et al., 2003).
Sensimotor-rhythm (SMR) training regime reinforces beta
power, usually low or mid beta, often with an inhibition target for
theta. The site is above the sensorimotor strip, often lateral, such
that the beta oscillations correspond to the sensorimotor rhythm.
The rationale for SMR training has been proposed as either
facilitating attention (Vernon et al., 2003), or the improvement
of sleep through an increase in beta spindles, with concomitant
effects on cognitive function (Arns et al., 2014a).
It is important to note, that NFB learning is anchored in
two scientific theories, but occurrence of NFB learning as such
tests only one of these. On the one hand, NFB learning relies
on the cortical arousal model of ADHD that emphasizes under-
arousal in the cortical systems with excess slow wave activity
affecting information processing (Sergeant et al., 1999; Barry
et al., 2003). Based on this model, the NFB training aims at
increasing fast-wave activity (in this study: SMR and beta bands)
and decreasing slow-wave activity (in this study: theta) (Barry
et al., 2003). However, NFB learning as such does not test whether
the underlying problem of ADHD is under-arousal; what it does
test is the operant conditioning of EEG activity. NFB learning
is conceptualized in terms of changes in the amount of time a
patient manages to move his/her EEG features in the required
direction during training sessions as a result of learning to self-
regulate cortical oscillations. Zuberer et al. (2015) argue that NFB
outcomes should be tested by examination of the learning curves.
Thus, it is clear that, although aetiological and thus clinical
specificity for ADHD is lacking, all NFB treatment regimes share
a common goal of promoting self-regulation. On the other hand,
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some more modern NFB regimes have a more explicit approach
to self-regulation than their older cousins. For example, Slow
Cortical Potentials (SCP) training uses two opposed cortical
regulation targets (Mayer et al., 2013), to be trained in random
consecutive order. The two most common NFB training regimes
TB and SMR do not include such an explicit set of counter-poised
targets to induce self-regulation, relying instead on a single target
of reinforcement/inhibition, which is trained repeatedly.
The target of SCP training is the Contingent Negative
Variation (CNV) Event Related Potential, which Mayer et al.
defined as a slow negative shift over central sites that develops
following the presentation of warning stimulus while expecting
an imperative stimulus that requires a response (Mayer et al.,
2015). Thus, while SCP directly addresses self-regulation, it does
so only for a single correlate of attention. Other cortical correlates
of attention processes are addressed by other NFB training
regimes, e.g., cortical hypo-arousal in TB, or spontaneous motor
activation in SMR. However, these training regimes have no
specific component designed to promote self-regulation.
Therefore, to the standard TB and SMR training regimes
we have introduced a mode of “inverse training” (denoted iTB
and iSMR), in order to explore the effect of adding an SCP-
like approach to these unidirectional training regimes. This
takes the form of an extra target in each regime, where the
reinforcer/inhibitor is the exact opposite of the norm (see
Methods).
TB and SMR training regimes are based on sub-second
frequency-band features, so they are not directly comparable with
SCPwhich feeds back the time domainDC component. However,
from our point of view, there are at least three motivating
reasons to test the “inverse training” self-regulatory modes of TB
and SMR.
First, the neurological effect of TB and SMR remains unclear,
due to the competing explanatory models. This study will not
lay all questions to rest, but it does pursue a novel line of
inquiry. Second, “inverse training” should aid the subjective
experience of self-regulation, as it does in SCP; after all from the
clinical point of view, NFB training in any training regime relies
on the patient’s own “mental strategy,” reinforced by feedback-
free transfer trials. Third, combining the above two issues,
the participants have the opportunity to learn the experiential
correlate of the inverse neural state, and thus learn to be able
to activate OR deactivate cortical resources at will. If we accept,
for example, that TB trains the activation of cortical arousal,
then the experiential correlate of inverse TB (iTB) might be
more appropriate when the individual needs to enter a state
of calm reflection. Similarly, SMR implies activation of the
sensorimotor strip, which in turn implies quietude of bodily
motor-neuron activity; however inverse SMR (iSMR) might be
more appropriate when particular task activity calls for so-called
kinaesthetic intelligence. This conceptualization of the process
would follow the “skill-acquisition” model of Gevensleben et al.
(2014). That is, the patient would gain a tool to enhance cognitive
performance, as opposed (or in addition) to repairing a presumed
cause of disorder.
Although earlier work (Lubar and Shouse, 1976; Monastra
et al., 2005), including meta-analysis by Snyder and Hall (2006),
has shown support for a single-trait model of ADHD (an elevated
theta-beta ratio), others have argued that research results and
clinical application should be interpreted with more regard for
variability of individuals (Arns et al., 2008). Hammond (2010)
goes into this issue in detail, illustrating the heterogeneity in
quantitative EEG (qEEG) patterns associated with symptoms
and discussing the requirements and need for qEEG analysis
guided by normative databases. Johnstone et al. (2005) provided
a review of such databases, along with a review of qEEG profiles,
which are manifestations seen between genome and behavioral
that they term “intermediate” EEG endophenotypes. They called
for QEEG endophenotype-guided NFB treatments to provide
non-pharmacological interventions to help the subgroup of non-
responders to traditional treatments, or complement traditional
treatments in certain cases.
Especially in adults, who are subject to maturation effects
across a broad age range, ADHD is a heterogeneous disorder
with an uncertain treatment situation. In other words, some
might have executive function deficits and might possibly benefit
from TB over the prefrontal cortex; while some might benefit
more from the characteristic behavioral correlate of SMR, that
is, immobility as well as reduction of muscular tension (Chase
and Harper, 1971; Howe and Sterman, 1972), thus facilitating
the self-regulation of attention through mechanisms similar to
mindfulness meditation (Zylowska et al., 2008). For this reason,
in this study TB and SMR training regimes are assigned in
a personalized fashion based on EEG spectral profiles (see
Methods).
1.2.1. Outline
In the rest of this paper, following the CONSORT guidelines, we
first document the Methods and design of the trial, including
participant criteria, intervention details, objectives, outcome
measures, sample size calculation, randomization procedure and
other allocation details, plus statistical analysis. Next, we provide
existing results from the trial as it stands, primarily regarding
how the treatment stage was run, along with preliminary
analyses of group comparison outcomes. Finally we discuss issues
arising from the trial design and implementation, as well as the
implications of the preliminary analyses and future work.
2. METHODS/DESIGN
2.1. Participants
Inclusion criteria were scores on Adult ADHD Self Report Scale
(ASRS) (Kessler et al., 2005), and Brown -ADHD scale (BADDS)
(Brown, 1996) indicating presence of ADHD, as well as:
• pre-existing diagnosis of ADHD or ADD,
• nonexistence of neurological diagnoses,
• age 18–60 years,
• IQ score >80measured by a qualified psychologist usingWAIS
IV (Wechsler, 2008)
Exclusion criteria included extreme outlier scores in the
scales of
• Generalized Anxiety Disorder (Spitzer et al., 2006),
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• Beck Depression Inventory (Beck et al., 1996),
• Alcohol Use Disorders Identification Test (Saunders et al.,
1993),
• the Mood Disorder Questionnaire (Hirschfeld et al., 2000),
• test of prodromal symptoms of psychosis (Heinimaa et al.,
2003), and
• the Dissociative experiences scale (Liebowitz, 1992) for
dissociative symptoms.
Thresholds for exclusion were not fixed but at the discretion of
the consulting psychiatrist. Use of medication for ADHDwas not
an exclusion criterion but participants were asked not to make
changes in medication during the time of the training. Informed
consent was obtained from each subject in accordance with the
Declaration of Helsinki.
Self-report tests were distributed and submitted by mail.
Psychiatric consultations were performed at the private practice
of the psychiatrist; IQ testing was performed at the testing
room of the University of Helsinki (UoH) Institute of Behavioral
Sciences (IBS); both in central Helsinki.
2.1.1. Ethical Approval
Written informed consent for participation was obtained from
all participants before entering the study. The protocol followed
the Declaration of Helsinki for the rights of the participants
and the procedures of the study. An ethical approval of the
present research protocol for all participants was obtained from
The Ethical Committee of the Hospital District of Helsinki and
Uusimaa, 28/03/2012, 621/1999, 24 §. Participants were not
remunerated.
2.1.2. Clinic of Treatment
The clinic for intervention sessions was required to be centrally
located in Helsinki, to be staffed by licensed psychiatrist in case
of emergencies, and to have recognition by the Association for
Finnish Work. Technicians were required to have a primary
degree in a discipline related to human psychology; they were also
required to take a 3-month training course provided at the UoH
based on principles of the Biofeedback Certification International
Alliance (BCIA).
2.2. Intervention
The experimental treatment was a novel neurofeedback
(NFB) intervention, based on the well-known operant
conditioning NFB training regimes “theta-beta” (TB) and
“sensorimotor rhythm” (SMR); with the novel addition of a
self-regulatory component designed to address the heterogeneity
and aetiological uncertainty of ADHD in the adult population.
The comparator was a WLC group. The WLC design places a
randomly assigned control group on hiatus, while the active
treatment is applied to the randomly assigned treatment group.
The WLC group should receive treatment after the follow-up
assessment at 24 months post-treatment, without experimental
oversight.
Participants who volunteered in response to advertisements
were recruited at time T0. Contact with the psychiatrist and
psychologist for screening followed at time T1.
Successfully screened participants were taken to the intake
measurement at time T2, where they performed the T.O.V.A.
test along with eyes-open and closed baselines, while scalp
EEG was recorded. The individual alpha peak frequency (IAPF)
of each participant was estimated from band power analysis
of eye-opened and eye-closed baseline conditions (Lansbergen
et al., 2011). The boundaries of each EEG frequency band for
each participant are defined with respect to IAPF, e.g., theta is
IAPF×0.4 to IAPF×0.6.
After randomization between treatment and WLC groups at
time T3, we assigned participants in the NFB treatment group
to either TB or SMR training based on their IAPF-adjusted
theta/beta ratio. Those with theta/beta ratio >1 (n = 9) received
reinforcement for simultaneous increase in beta and decrease
in theta (over power estimated from per-session baseline) at
electrode Fz. The rest (n = 16) got reinforcement for increase in
SMR and decrease in theta at electrode C4. Band powers within
the NFB training regimes are adjusted by IAPF.
Treatment was administered using the following hardware
and software set up. The EEG amplifier was the Enobio
ambulatory device (Neuroelectrics SL, Barcelona)2, with
streaming Bluetooth connection to standard Windows 8 desktop
computers. The software was developed within the project, as
described in Cowley et al. (forthcoming). Briefly, the system is
based on OpenViBE signal acquisition framework3, with a Qt
frontend, and is available open source4.
NFB interventions were standardized by scheduling of the
training sessions: session duration was fixed; and training blocks
per session, sessions per week, timing of the break from training,
and total duration of training were all constrained to equalize
the intervention. At time T4, treatment group participants
began their treatment by being briefed about all aspects of the
NFB training regimes, e.g., length, frequency, purpose. Finally
for the first phase, outcome measures were taken at time T5,
when all participants in the treatment group had completed 40
sessions NFB.
In the first phase the care providers were monitored
by both the lead researcher and responsible psychiatrist on
separate occasions, with interviews to ascertain their self-
assessment of performance. Both care providers and patients
were given self-assessment questionnaires to describe their
working relationships.
The second phase of the trial is ongoing at time of writing.
Beginning with re-recruitment at T6, phase two consists of a
follow-up measurement for all, and treatment option for WLC
participants. Follow-up measurements include the ASRS and
BADDS self-reports. Treatment for the WLC group will not
be NFB, but will consist of a game-like computerized attention
training intervention, without concurrent recording of EEG.
2.3. Objectives
Our RCT research questions (RQs) follow Calderon and
Thompson (2004), since we first examine NFB learning “within
subjects,” and second examine the transfer of NFB learning
2http://www.neuroelectrics.com/.
3http://openvibe.inria.fr/.
4https://github.com/CBRUhelsinki/CENTplatform.
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comparing the treatment group to a WLC group. Within this
paper, we report only first-stage analysis, namely the comparison
between groups addressed by H2a and H3c below (see Results).
2.3.1. Learning in NFB
The NFB learning metric reflects the proportion of time during
training when EEG signals are in the target state; the “learning
curve” is thus characterized by a signal evolving over blocks
and sessions of training. The shapes or slopes of participants
LCs are rarely reported in the NFB literature: analysis tends
to focus on transfer outcomes compared to a control group.
However, clinical observations commonly indicate that learning
occurs. Also, NFB learning in this study was manipulated with
the addition of the “inverse-training” mode. The LCs resulting
from normal, inverse and transfer training blocks should each
be slope-positive, because they each require a similar act of
concentration which the participants are practicing throughout
training. Finally, the profile of the LCs over sessions which
combine all training types should be slope-positive, because
training with counter-poised targets increases the need to self-
regulate. Thus, we propose the following hypotheses:
• H1a: “normal” NFB training results in positive-slope LCs.
• H1b: “inverse” NFB training results in positive-slope LCs.
• H1c: “transfer” NFB training results in positive-slope LCs.
2.3.2. Transfer: Attention Test and Self-Reported
Symptoms
Due to meta-analyses that find that NFB is efficacious for
reduction of inattention (Arns et al., 2009), transfer of learning
is expected to result in more improvement-over-baseline of
the treatment group, compared with a control group, at
the continuous performance test (CPT) Test Of Variables
of Attention (T.O.V.A.) applied before and after training.
Furthermore, those participants who perform better in baseline
T.O.V.A. (lower scores), are expected to learn quicker during the
NFB training.
• H2a: the treatment group will achieve better T.O.V.A.
performance, and improve more after training, than theWLC.
• H2b: a better baseline T.O.V.A. score will predict better
baseline NFB performance and better NFB learning.
Severity of subjective symptoms of ADHD/ADD should be
reduced by the transfer of NFB learning to the ability to self-
regulate. We also expect this effect to be dose-dependent, such
that participants with better NFB performance (steeper positive
slope) should present a higher rate of change in reported
symptoms (steeper negative slope). Finally, the treatment group
is expected to report fewer symptoms than the control group in
the outcome measurement.
• H3a: NFB training will result in a negative linear trend in
reported ADHD/ADD symptoms.
• H3b: the NFB LC profile will correlate with reported
ADHD/ADD symptoms.
• H3c: the treatment group will report greater improvements in
ADHD/ADD symptoms than the WLC.
2.4. Outcomes
Primary outcome measures include learning curve assessment,
T.O.V.A., ASRS, and Digit span. These measures fall into
two categories: (1) between-group comparison of NFB and
WLC groups; and (2) within-subjects tests for treatment group.
Primary measures are all comparative, truly experimental, and
hypothesis-driven.
Secondary outcomemeasures include pre- and post-treatment
vigilance measurement with an EEG protocol (Olbrich et al.,
2012); also per-session self-report of circadian patterns, mood,
excitement, effort and frustration; and the Pittsburgh Sleep
Quality Index (PSQI) administered pre-, post- and at two
intermediate points during treatment. These measures were
taken to explore the additional research question of the
relationship between sleep quality and NFB performance.
Additional methods taken to assess the quality of
measurements include
• placebo expectation reports (Borkovec and Sibrava, 2005)
asked before and at halfway through the treatment,
• the novel participant-technician interaction questionnaire,
designed to assess the participants’ experience of their
interaction with the technician. Based on the guidelines of
the “Framework for Measuring Impact”5, we created what
they term “specifically developed questions.” This option
was especially appropriate given the requirement to translate
any existing measure, which would limit validity. The
questionnaire was a set of ten simple questions such as “has
my trainer supported me during my neurofeedback training?”
Responses were made on a six-point Likert-scale from “0-not
at all” to “5-enough," for a scoring range of 0–50.
2.5. Sample Size
The power calculation of N = 60 was based on an estimated
effect size for neurofeedback of 0.9, alpha at 0.05 and Power
at 0.95 (for an independent samples t-test, estimate based on
studies including Egner and Gruzelier, 2004; Rossiter, 2004a,b;
Arns et al., 2009). Recent work has shown an effect size of 0.73
for a purely adult population (Mayer et al., 2012), but we can
still maintain N = 60 by assuming power = 0.85, since this is
equivalent to an phase 1 trial where the motivation is greater to
minimize Type I error than Type II. This also contributes to our
motivation to use a WLC along with the principle that NFB is
closer in nature to a behavioral intervention than a drug trial, and
thus double-blinding is unwarranted and unethical.
2.6. Randomization Procedure
We assign patients to test or control groups using a procedure
that controls for selection bias, and known and unknown sources
of external variance due to prognostic variables; the procedure is
based on combined randomization and adaptive allocation.
Simple randomization prevents biased selection andmeets the
assumptions of uniform assignment probabilitymade in standard
inferential procedures. However, it does not guarantee equal
group sizes and can lead to baseline imbalance in prognostic
variables such as age, gender or disease severity. Equal group sizes
5http://www.measuringimpact.org/home.
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can be obtained using blocking, while baseline imbalance can
be helped by using blocking stratified over prognostic variables,
although the number of variables which can be used is small. This
limitation is surmounted by adaptive allocation, exemplified by
minimization methods: these are not strictly random but allow
tight control of balance of multiple prognostic variables (see e.g.,
Roberts and Torgerson, 1998 on methodological issues).
In their review of recommendations of assignment method,
(Scott et al., 2002, p. 671) found a general support for
minimization with a random element in smaller trials. Our
approach follows: X% random blocking followed by 100-X%
minimization (0<X<100). The algorithm is:
1. Simple blocked random allocation of X% patients (of those
currently recruited).
2. For the next 100−X% of patients, reassign patients based on
minimization.
3. Using a distance measure, make the assignment that results in
the smaller inter-group distance.
4. For every new assignment decrement the number of possible
new assignments to that group, to maintain equal group sizes.
Assignment was balanced over age, sex, education, IQ, diagnosis
(ADHD vs. ADD), comorbities from diagnosis, comorbities from
administered scales, and ASRS subtype score, and tested between
groups to show no statistically significant differences (see Table 1
below). The same tests returned null when run after any change in
relative group composition, due to e.g., drop-outs. Thus, groups
did not differ in terms of symptom severity, diagnosis, IQ or
demographic features at assignment.
Given that the initial allocation of patients is random, further
non-random selections will also be random at the population
level. Even if the minimization assignments cannot be considered
random, the overall assignment retains a proportional amount
TABLE 1 | Demographic and clinical characteristics for NFB and WLC
groups.
Treatment Control Statistical testing
N = 25 N = 29 t df p
Age Mean 35.72 36.45 −0.259 52 0.797
Std. Dev. 9.66 10.86
WAIS-IV: VCI Mean 113.68 113.59 0.035 52 0.972
Std. Dev. 10.33 9.37
WAIS-IV: POI Mean 113.44 112.69 0.194 52 0.847
Std. Dev. 11.87 15.87
χ
2 df p
Gender Female 14 (56%) 15 (52%) 0.99 1 0.753
Male 11 (44%) 14 (48%)
Education Primary 6 (24%) 5 (17%) 0.470 2 0.791
Secondary 15 (60%) 18 (62%
Tertiary 4 (16%) 6 (21%)
ADHD/ADD ADHD 21 (84%) 23 (79%) 0.196 1 0.658
ADD 4 (16%) 6 (21%)
of randomness equivalent to X, similar to more complex
biased-coin approaches. In this trial X was set equal to 50.
The most important caveat of the approach is that variables
used in minimization must be included as covariates during
analysis, to avoid potentially misleading results.
Technicians must be assigned to treatment and control group
by recruitment on-demand, as the group treatment phases were
separated in time.
2.6.1. Allocation Concealment
Participants were randomly assigned by use of computerized
algorithm detailed above, at one time, directly after all intake
measurements and before the start of NFB treatment.
2.6.2. Implementation
The allocation algorithm was designed and implemented by the
lead researcher; the direct contact with participants for enrolment
and assignment was handled by a technician working for the
MCC clinic.
2.6.3. Blinding
Due to the fact that the trial used waiting list for the control
group, assessment was not blinded. Thus, after assignment,
all participants and researchers/technicians had access to the
assignment information. Asmentioned above, since NFB is closer
in nature to a behavioral intervention than a drug trial, double-
blinding would be unwarranted and unethical.
2.7. Statistical Methods
Independent variables for group comparison include NFB
training regime (TB vs. SMR), participant age and gender, and
assigned group (treatment vs. WLC group). Dependent variables
(DVs) for group comparison include the T.O.V.A. and the ASRS
self-report.
T.O.V.A. variables, based on response times (RT) and error
rates, include RT variability (RTV) indicating consistency; mean
RT; Omission errors (OM) indicating inattention; Commission
errors (COM) indicating impulsivity; as well as the D-prime
score. D-prime is described as a measure of “perceptual
sensitivity” and has been suggested as an index of arousal (Losier
et al., 1996). T.O.V.A. variables are standardized in the analysis.
To evaluate the effect of NFB on T.O.V.A., we created
five new variables by subtracting the baseline scores from
the outcome measurement scores: RTV-change, mean RT-
change, OM-change, COM-change, and D-prime-change. These
T.O.V.A. change scores are subsequently compared for the
treatment group and theWLC, using independent samples t-test.
The Levene’s test showed that the variances for the two groups
were similar. Consequently, the independent samples t-test was
run with equal variances assumed.
MANOVAwas subsequently used to evaluate the effect of NFB
training, compared to the WLC, in the outcome measures on the
five dependent variables of T.O.V.A.
ASRS consists of 18 items tapping the frequency of recent
DSM-IV criterion symptoms of adult ADHD, including a scale
for Inattention (IA, max 36 points) and a scale for Hyperactivity-
Impulsivity (HI, max 36 points). We calculated differences of
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scores between baseline and outcome measurements to create
IA-change and HI-change scores. These difference scores are
subsequently compared for the NFB and the control group, using
independent samples t-test.
The Levene’s test showed that the variances in IA-change were
statistically significantly different in the two groups (F = 4.36, p
< 0.05). As a result, the independent samples t-test for IA-change
was run with equal variances not assumed. The opposite was the
case for the variable HI-change.
In all our random coefficient models the intercept and
slope are separately estimated for each participant. That is, the
coefficients are estimated for each participant for the linear
regression equation as follows: Score= Intercept+ B (Session).
All participants were treated with NFB at a single center.
All technicians were equivalently trained and capable; therefore
clustering of participants per technician was based simply on
scheduling logistics.
3. RESULTS
Results primarily describe the specific details of the intervention
implementation. Also, as stated, a preliminary between-subjects
comparison was performed after phase one to assess intervention
efficacy under a conventional analysis model. Thus, we report the
two straightforward pre- to post-treatment outcome measures
which are comparable between-groups: T.O.V.A. and ASRS. The
ambiguous results of this conventional approach, especially in an
unblinded context, supports themotivation to extend the analysis
with LC modeling. We therefore include these results in the
protocol report because they constitute an informative part of the
trial design going into the second phase.
3.1. Participant Flow
Eighty-two adults were recruited through cooperating clinics
Mental Capital Care, Neuromental and YTHS; also by newspaper
advertisement and posting to online forums for the Helsinki-
based ADHD society of Finland. Of this, 19 dropped out of
the trial before completing the screening process, due to various
issues.
Sixty-three participants were screened by a psychiatrist and a
psychologist prior to the training, resulting in nine participants
screened out of the trial due to one or more failures to meet
the criteria. The remainder (n = 54) consisted of 29 females, 25
males, mean age 36 std.dev. 10 years, with 44 ADHD and 10 ADD
diagnoses.
Participants were split equally between treatment (n = 27)
and control groups (n = 27); however two switched from
treatment group (final n = 25) to control group (final n = 29)
for personal reasons. From these assignments, eight dropped out
from the WLC group (including one participant whose pre-test
measurement data was then deleted by request), and two from
the treatment group. Thus, 23 treatment group, and 21 WLC
group cases (total n = 44) were available for analysis. The trial
progression is shown in detail in Figure 1.
Out of those who completed NFB, five participants did not
complete treatment on the pre-defined schedule, of which three
exceeded by more than a week. Delays were due to personal
reasons, causing a number of cancelations of scheduled sessions,
which is a regularly observed phenomenon in this diagnostic
group.
3.1.1. Implementation of Intervention
In practice, NFB training consisted of ∼40 sessions (range: 38–
41) during 2–4 months. There was a mid-training pause of
nominally 2 weeks. Patients came to the sessions 2–5 times
a week. One session lasted ∼1 h, subdivided into self-report
of mood, excitement, hours slept and hours awake; electrode
attachment; baseline measurement; 5–7 units of 5 min NFB trials;
and debrief including self-report of effort and frustration. During
each session, patients played different NFB “game” trials during
which they got immediate visual reinforcement for classifier-
matching states in their EEG. The scores per game trial are
baseline-adjusted and averaged per session to form characteristic
LCs. The content and purpose of the training sessions followed a
phased timeline:
1. Tutorial stage, for becoming accustomed to NFB, two practice
sessions: participants were given normal NFB trials with
baseline thresholds adjusted by a constant factor to make the
training easier;
2. Beginner stage, for NFB training, 18 sessions up to halfway
break: normal NFB with non-adjusted baseline thresholds;
3. Intermediate stage, for learning to self-regulate, ten sessions
from half-way to session 30: normal training blocks were
gradually reduced in number to half per session, and inverse
training blocks introduced in their place;
4. Expert stage, for transfer training, ten sessions until session 40:
as Intermediate stage, but also with one to two “transfer” trials
with no feedback stimuli.
3.1.2. Recruitment
As shown in Figure 1, participants were recruited in May/June
2012, with intake measurements during July/August 2012.
Randomization took place in early September; treatment began
September 17, 2012. Outtake measurements ran from April until
August 2013.
Follow-up measurements are planned for start of 2016.
3.2. Baseline Data
The participants who began the trial (n = 54, 29 females) had
mean age 36 years (std.dev. 10 years), with 44 ADHD and 10
ADD diagnoses. The characteristics per group are shown below
in Table 1.
All intervention sessions were performed at the Mental
Capital Care (MCC) clinic premises in Helsinki, which met all
requirements described above. Technicians were recruited to
administer the NFB from IBS and MCC; they were trained at
UOH over a 3 month period; four of the team also attended
the Biofeedback Certification International Alliance (BCIA)-
accredited introductory course at the Brainclinics education and
treatment center, Netherlands.
3.2.1. Numbers Analyzed
The analysis included 23 participants in the treatment group, and
21 participants in the WLC group. Given that dropouts were not
analyzed, this analysis was not by intention-to-treat.
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FIGURE 1 | Flow chart of assessments and treatments in the CENT trial.
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3.3. Outcomes and Estimation
For H2a we find no support after analysis of the five
T.O.V.A. indexes; Table 2 shows their mean differences between
baseline and post-training. Changes in these variables were not
significantly different for the NFB group than for the WLC.
Results of the MANOVA at the outcome measurement revealed
that on the Wilks’ Lambda the difference in means between the
NFB and WLC did not reach significance [F(5, 38) = 0.45, p
>0.05]. Thus, NFB training had no significant effect on the 5
indexes of T.O.V.A. at the end of the intervention.
Table 3 presents the mean difference of the two indexes
between baseline and post-training and the results of the
independent sample t-tests comparing IA-change and HI-change
between NFB group and WLC. The NFB group presented
a higher reduction of inattention symptoms than the WLC
t(36.03) = −2.14, p < 0.05. Similarly, while the NFB group
presented a reduction of HI symptoms from baseline to post-
training, the WLC presented an increase in HI symptoms
t(44) = −2.42, p < 0.05. Thus, we find statistically significant
support for H3c. That is, the treatment group reported greater
improvements in ADHD/ADD symptoms than the WLC.
Amore detailed analysis concerning the rest of the hypotheses
will follow in a separate paper. As treating the hypothesesH1a-b,
H2b, and H3a-b requires substantial additional methodological
reporting, addressing them does not fit the scope of a clinical trial
report.
3.3.1. Adverse Effects
No adverse effects were observed in the treatment group. Further
investigation of this question is planned for follow-up, using the
state-oriented self-report items described above.
4. DISCUSSION
4.1. Interpretation
Regarding the relationship between NFB learning and
performance in the continuous performance test, H2a proposed
that the NFB group will achieve better T.O.V.A. performance,
and improve more after training, than the WLC. Results of
this study did not find evidence for such transfer. Patients
participating in the NFB training did not perform better than
WLC on the 5 indexes of T.O.V.A. in the outcome measurement.
This result can be interpreted in at least two ways. On the one
hand, it can be a sign of the all too common problem of transfer
of training (Green and Bavelier, 2012).
Lack of transfer is one of the most important of the several key
obstacles pertaining to the effect of NFB trainings (Gazzaniga,
2009, p. 94). Because brain plasticity is highly task specific,
training in a specific task shows little or no improvement on
related tasks. On the other hand, the results of this study can
mean that NF learning bears no relationship to performance
on any indexes of the T.O.V.A. test. This would contradict the
findings of Losier et al. (1996) who considered the D-prime index
of T.O.V.A. a consensus index of arousal, which is, in turn,
assumed to be a manifestation of excessive slow wave brain waves
in ADHD patients (Barry et al., 2003).
TABLE 2 | Groups statistics for RTV-change, mean RT-change,
OM-change, COM-change and D-prime-change scores from baseline to
outcome.
N Mean Std. t df p
RTV-change 0.343 42 0.739
NFB group 23 −5.56 40.13
WLC 21 −9.44 34.15
Mean RT-change 0.132 42 0.896
NFB group 23 −3.37 16.23
WLC 21 −3.94 11.85
OM-change 1.19 39 0.240
NFB group 23 10.10 72.73
WLC 21 −46.25 198.84
COM-change 0.517 42 0.608
NFB group 23 6.19 27.49
WLC 21 1.81 28.67
D-prime-change −0.016 42 0.987
NFB group 23 1.50 45.30
WLC 21 1.72 44.73
TABLE 3 | Groups statistics for IA-change and HI-change scores.
N Mean Std t df p
IA-change −2.14 36.03 0.039
NFB group 25 −1.2 2.17
WLC 21 −0.14 1.06
HI-change −2.42 44 0.020
NFB group 25 −1.08 2.31
WLC 21 0.38 1.65
H3c suggested that the NFB group will report greater
improvements in ADHD symptoms than the WLC. Results
show the change of IA was significant. Patients did perceive
a reduction of inattention symptoms over the course of the
training. Furthermore, this perceived reduction of inattention
symptoms differed significantly from the perceived reduction of
inattention symptoms of the control group. This supports the
meta-analysis by Arns et al. (2009) concluding that NFB has
large effect sizes on inattention. In the index of HI, no negative
linear trend was found. Interestingly however, patients in the
NFB group did perceive a significantly larger reduction of these
symptoms over the course of the training than the control group.
It might be that the training indeed resulted in some reduction
of IA and HI symptoms. This interpretation gets support
from theories claiming that ADHD is, in effect, pathology of
executive functions that cannot be tapped by neurocognitive
tests, but can instead bemeasured by self-reported questionnaires
(Rabbitt, 1997; Brown, 2009, pp. 81–116). Alternatively, the
results can also be interpreted as an example of the so called
Hawthorne effect (Green and Bavelier, 2012). Establishing the
presence of experience-dependent learning effects is not always
straightforward. It is well documented, that individuals who take
an active interest in their performance tend to improve more,
or evaluate their improvement more positively. The Hawthorne
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effect can lead to powerful subjective improvements that have
little to do with the specific cognitive training regimen being
studied reflecting motivational factors instead.
If the training caused the decreased symptoms, a higher rate
of learning should have a relationship to the rate of ADHD
symptom decrease under the training. Therefore further analyses
of this trial will examine the relationship between NFB LCs and
the trend of self-reported ADHD symptoms.
Also, the different learning performance levels across the
group should reflect different long term effects, to be measured
during the second phase in a within-subjects analysis. This
contrasts with the effect from the interaction-derived placebo
which is relatively constant for all participants (per group),
and presumably “fades away” quickly after the phase one
intervention. Thus, second phase measurements will be analyzed
with respect to NFB LCs.
Though this is a relatively small study, we believe the analysis
of learning curve questions is a novel and useful contribution. As
noted by Arns (personal communication, 2012):
“In any Neurofeedback study it is very important to track
and have an indication of ‘learning.’ If neurofeedback fails to
demonstrate a clinical effect and there is no indication that
learning actually took place, one can’t draw any conclusions
about neurofeedback. In an analogy, if one employs operant
conditioning to [teach] a rat to press a lever, and the rat does
not learn to press the lever, then it is incorrect to conclude that
‘operant conditioning’ does not work. This means that maybe the
operant conditioning procedure was not implemented effectively.
The same applies to neurofeedback, and this is further illustrated
by the study from Roger DeBeuss. His study employed sub-
optimal parameters e.g., auto-thresholding, ‘game’ feedback and
an ‘unconventional’ training regime (engagement index) making
it likely harder to learn. On the group level they found no effects
of neurofeedback in ADHD, however, when separating learners
from non-learners based on session data they did find an effect.”
Questions of efficacy on the other hand are still a matter of
controversy in the literature. WLC controls are not accepted as
sufficient evidence by some. Double blind control through sham
NFB was not chosen for this study because of the discussed lack
of general understanding of ADHD. This lack, combined with the
extremely contingent nature of NFB which depends heavily on
non-specific aspects of treatment, implies that even if a double
blind RCT showed large effect for NFB the causal mechanisms
would still not be clear. A true resolution to this issue is probably
only possible by running the kind of large sham NFB RCT called
for by others; we choose instead to side-step this debate and focus
on questions of internal comparisons within the method.
There is no blinding in this open-label WLC study, except at
random assignment to groups. Other control paradigms may be
preferred in pharmacological interventions; however there are a
number of arguments in support of WLC, in the context of NFB.
The WLC is a minimum viable control for non-specific effects of
history, maturation, repeated testing, instrument drift, statistical
regression, selection bias, and population inhomogeneity effects
(Mohr et al., 2009). There is no control for non-specific or
placebo effects; however this is still a valid experimental control
design. Among other things, WLC controls for expectation and
attention (Hawthorne) effects, whereby the notion that at some
future point treatment will be provided (and life will improve) is
by itself able to produce improvement. Additionally, longitudinal
(rather than parallel) designs control for maturation, regression
to the mean, instrument drift and practice effects; also time
threats to validity (the same effect occurring 2 years in a row
in different samples rules out external non-seasonal temporal
causes for the effect. Seasonal causes with a WLC group should
be ruled out by staggered application i.e., 2nd treatment starting
in spring).
Technicians can be considered equally skilled and expert. All
began as neurofeedback novices before the trial. Qualification
history was varied. Due to availability, only some began
their training with attendance at the Biofeedback Certification
International Alliance (BCIA)-accredited introductory course at
the Brainclinics education and treatment center, Netherlands.
However, all five then shared 3 months training at UoH
premises, including extensive peer review work, which helped to
disseminate and pool the knowledge across the group.
4.2. Generalizability
External validity asks the question of “generalizability”: to
what populations, settings, treatment variables and measurement
variables can this effect be generalized? While the question of
external validity is never completely answerable, it is of particular
interest for intervention research (Campbell et al., 1966, pp.
171–246). Campbell et al. (1966) note that there is a recurrent
reluctance among researchers to accept Hume’s truism that
induction or generalization is never fully justified logically. While
the problems of internal validity are solvable within the limits
of the logic of probability statistics, the problems of external
validity are not logically solvable in any neat, conclusive way
(Campbell et al., 1966, p. 17). Generalization always involves
extrapolation into a realm not represented in one’s sample. Here,
the issue of sample bias is of importance. If an experimental
study is conducted with voluntary patients from a given district,
they might have characteristics that cause the experimental
treatment to be more effective than it would be in other
populations. However, for ethical reasons, intervention studies
are impossible to conduct without the informed consent of the
research subjects. It is obvious, that a “true” experimental design
is in practice impossible with a fully representative sample of
a given country, let alone all ADHD patients in the world. It
must be emphasized that the results of an experiment “probe”
but do not "prove" a theory. An adequate hypothesis is one
that has repeatedly survived such probing, but it may always
be displaced by a new probe. Many findings in experimental
psychology gain generalizability not through the nature of the
setting in which they occurred, but through their ability to
establish a theory of basic mental processes that are implicated in
many tasks.
4.3. Overall Evidence
After preliminary analysis, the trial did not find evidence
for a transfer of learning that was the intended benefit of
the intervention. Since the intervention’s goal is symptomatic
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improvement outside the laboratory, the results underline how
the transfer-problem limits the potential benefits. Patients did
perceive a reduction of Inattention symptoms over the course of
training, yet this change was not reflected in better performance
in the continuous performance test (T.O.V.A.).
We propose that in the absence of any other evidence, one
should consider these self-report results as due to placebo by
default. The improvement in self-reported symptoms might not
be specifically due to NFB, but due to employment of goal-
oriented attention in general. At present, we can not rule out the
possibility that the individuals would also report improvement
if all other factors were held equal but NFB was swapped for
some other exercise that requires concentration. That is, our
preliminary results did not support the effectiveness of NFB in
alleviating the symptoms of AHDH/ADD.
Nevertheless, keeping in mind the core aim of studying
mechanisms and models of NFB, the CENT trial is on track
to provide the necessary evidence. As Seidman (2006) suggest,
an adequate neuropsychological model of ADHD should utilize
measures from multiple domains to be able to encompass
subtypes and multiple deficits. Combining neuropsychological,
neurophysiological and behavioral measures, we aim toward an
evaluation of structure-function relationships in NFB treatment
for adult ADHD.
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